Nombre del producto |
4-[2-[(2R,3R)-3-(2,4-difluorofenil)-3-hidroxi-4-(1,2,4-triazol-1-il)b utan-2-il]-1,3-tiazol-4-il]benzonitrilo |
Sinónimos |
Ravuconazol [DCI]; BMS 207147; ER 30346; Ravuconazol; p-(2-((alfaR,betaR)-2,4-difluoro-beta-hidroxi-alfa-metil-beta-(1H-1,2,4-triazol-1-ilmetil)fenetil)-4-tiazolil)benzonitrilo; Benzonitrilo 4-(2-((1R,2R)-2-(2,4-difluorofenil)-2-hidroxi-1-metil-3-(1H-1,2,4-triazol-1-il)propil)-4-tiazolil)-; 4-{2-[(1R,2R)-2-(2,4-difluorofenil)-2-hidroxi-1-metil-3-(1H-1,2,4-triazol-1-il)propil]-1,3-tiazol-4-il}benzonitrilo |
Nombre en inglés |
4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)b utan-2-yl]-1,3-thiazol-4-yl]benzonitrile;Ravuconazole [INN]; BMS 207147; ER 30346; Ravuconazole; p-(2-((alphaR,betaR)-2,4-Difluoro-beta-hydroxy-alpha-methyl-beta-(1H-1,2,4-triazol-1-ylmethyl)phenethyl)-4-thiazolyl)benzonitrile; Benzonitrile, 4-(2-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)-; 4-{2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-1,3-thiazol-4-yl}benzonitrile |
Fórmula molecular |
C22H17F2N5OS |
Peso Molecular |
437.4651 |
InChI |
InChI=1/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1 |
Número de registro CAS |
182760-06-1 |
Estructura Molecular |
|
Densidad |
1.38g/cm3 |
Punto de ebullición |
674.9°C at 760 mmHg |
Índice de refracción |
1.665 |
Punto de inflamación |
362°C |
Presión de vapor |
3.89E-19mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|